Početna › Ateroskleroza › Texas

Kliničke studije za Ateroskleroza u državi Texas

11 studija za Ateroskleroza traži sudionike na lokacijama u državi Texas.

Gradovi u državi Texas

Službeni tekst studije (engleski)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Horizon Clinical Research Group, Cypress
Cardiovascular Specialists of Willowbrook, Houston
Texas Cardiology Associates of Houston, Kingwood
i još 2

U tijeku regrutacijaFaza 2

Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07783802

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

Southwest Family Medicine Associates, Dallas
East Texas Cardiology PA, Houston
Cardiovascular Specialists of Willowbrook, Houston
i još 1

U tijeku regrutacijaFaza 2

Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07448038

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

PharmaTex Research, Amarillo
St. David's Heart & Vascular PLLC dba Austin Heart, Austin
Velocity Clinical Research, Austin, Austin
i još 18

U tijeku regrutacijaFaza 3

Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

PharmaTex Research, LLC, Amarillo
Austin Heart, Austin
Velocity Clinical Research - Austin, Austin
i još 22

U tijeku regrutacijaFaza 3

Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

PharmaTex Research, LLC, Amarillo
Pulse Care Heart and Vascular, Carrollton
DM Clinical Research - Dallas, Tomball

U tijeku regrutacijaFaza 2

Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07521007

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

Cussimanio Research Group LLC, Austin
Research Management, Inc., Austin
MW Clinical Research Center, Beaumont
i još 22

U tijeku regrutacijaFaza 2/3

Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Research Site, Amarillo
Research Site, Beaumont
Research Site, Brownsville
i još 33

U tijeku regrutacijaFaza 3

Od 18 godina i više · Oba spola · Ažurirano 24. kol 2026. · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

PharmaTex Research LLC, Amarillo
Kelsey Seybold Research Foundation, Houston
Northwest Houston Clinical Research PLLC, Tomball

U tijeku regrutacijaFaza 3

Od 18 do 80 godina · Oba spola · Ažurirano 7. kol 2026. · NCT06813911

Pelacarsen Roll-over Extension Program

Plano Primary Care Clinic, Allen
Pharma Tex Research, Amarillo
SW Family Medicine Associates, Dallas
i još 8

U tijeku regrutacijaFaza 3

Od 18 do 100 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06875973

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Michael E. DeBakey VA Medical Center, Houston, TX, Houston

U tijeku regrutacijaFaza 4

Od 18 godina i više · Oba spola · Ažurirano 17. pro 2025. · NCT02915198

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

UT Health Houston, Houston

U tijeku regrutacijaFaza 2

Od 40 godina i više · Oba spola · Ažurirano 17. pro 2025. · NCT05488431

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.